Barrett's oesophagus:: from metaplasia to dysplasia and cancer

被引:88
作者
Fléjou, JF [1 ]
机构
[1] CHU St Antoine, Hop Paris, Serv Anat Pathol, F-75571 Paris, France
关键词
D O I
10.1136/gut.2004.041525
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Barrett's oesophagus is a premalignant condition that predisposes to the development of oesophageal adenocarcinoma. it is detected on endoscopy and confirmed histologically by the presence in the lower oesophagus of a metaplastic mucosa, the so-called specialised epithelium, which resembles incomplete intestinal metaplasia in the stomach. These similarities with incomplete intestinal metaplasia are present on histology, mucin histochemistry, and immunohistochemistry with various differentiation markers (cytokeratins and MUC antigens). On morphology, the carcinogenetic process of Barrett's mucosa progresses through increasing grades of epithelial dysplasia. Dysplasia, a synonym of intraepithelial neoplasia, is the only marker that can be used at the present time to delineate a population of patients at high risk of cancer. Among the numerous molecular events that have been shown to play a role in the neoplastic transformation of Barrett's mucosa, only changes in DNA ploidy, increased proliferation, and alterations of the p53 gene have been suggested to be of potential help in the surveillance of patients.
引用
收藏
页码:I6 / I12
页数:7
相关论文
共 69 条
[1]   Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice [J].
Alikhan, M ;
Rex, D ;
Khan, A ;
Rahmani, E ;
Cummings, O ;
Ulbright, TM .
GASTROINTESTINAL ENDOSCOPY, 1999, 50 (01) :23-26
[2]  
[Anonymous], WHO CLASSIFICATION T
[3]   Cellular and molecular mechanisms responsible for progression of Barrett's metaplasia to esophageal carcinoma [J].
Beilstein, M ;
Silberg, D .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2002, 31 (02) :461-+
[4]   Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma [J].
Buttar, NS ;
Wang, KK ;
Sebo, TJ ;
Riehle, DM ;
Krishnadath, KK ;
Lutzke, LS ;
Anderson, MA ;
Petterson, TM ;
Burgart, LJ .
GASTROENTEROLOGY, 2001, 120 (07) :1630-1639
[5]  
Cameron AJ, 1997, AM J GASTROENTEROL, V92, P586
[6]   High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus:: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins [J].
Chatelain, D ;
Fléjou, JF .
VIRCHOWS ARCHIV, 2003, 442 (01) :18-24
[7]   Significance of acid-mucin-positive nongoblet columnar cells in the distal esophagus and gastroesophageal junction [J].
Chen, YY ;
Wang, HH ;
Antonioli, DA ;
Spechler, SJ ;
Zeroogian, JM ;
Goyal, R ;
Shahsafaei, A ;
Odze, RD .
HUMAN PATHOLOGY, 1999, 30 (12) :1488-1495
[8]  
Chinyama CN, 1999, HISTOPATHOLOGY, V35, P517
[9]   Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology [J].
Couvelard, A ;
Cauvin, JM ;
Goldfain, D ;
Rotenberg, A ;
Robaszkiewicz, M ;
Fléjou, JF .
GUT, 2001, 49 (06) :761-766
[10]   Can extent of high grade dysplasia in Barrett's oesophagus predict the presence of adenocarcinoma at oesophagectomy? [J].
Dar, MS ;
Goldblum, JR ;
Rice, TW ;
Falk, GW .
GUT, 2003, 52 (04) :486-489